Literature DB >> 32336840

Chapter 8 Paramyxoviruses.

.   

Abstract

The paramyxoviruses are a heterogeneous group of viruses causing a variety of clinical diseases in humans, animals, and birds. This chapter examines in more detail the structure and properties of the important human viruses in this group, namely measles, respiratory syncytial virus (RSV), mumps and parainfluenza viruses I-V. They are all enveloped, negative-stranded, riboviruses of helical symmetry. It is suggested that susceptible children, adolescents, and adults should be vaccinated against mumps, unless vaccination is contraindicated. Mumps vaccine can be of particular value to children approaching puberty and for adolescents and adults, especially males who have not had mumps in childhood. Ribavirin therapy may be particularly beneficial for children at risk for severe and often fatal RSV infection, such as infants with congenital heart disease. Attenuated measles vaccines have been developed empirically by selection of host range mutants, and are widely and successfully used throughout the world. Using the vaccine, some countries may soon eliminate measles as an endogenous virus but continued problems are anticipated, particularly in adults with viruses re-introduced by visitors from abroad. Basic studies on new antivirals are continuing (particularly with oligopeptides) but antiviral compounds are unlikely to have extended use in the clinic, except perhaps in tropical areas where the disease may be life threatening. However, a vaccination programme in these areas is preferable, and is an urgent need. © 1985.

Entities:  

Year:  2008        PMID: 32336840      PMCID: PMC7172905          DOI: 10.1016/S0168-7069(08)70016-8

Source DB:  PubMed          Journal:  Perspect Med Virol        ISSN: 0168-7069


  159 in total

1.  Para-influenza viruses 1, 2, and 3: suggested names for recently described myxoviruses.

Authors:  C H ANDREWES; F B BANG; R M CHANOCK; V M ZHDANOV
Journal:  Virology       Date:  1959-05       Impact factor: 3.616

2.  Isolation of a new virus from a child with an influenza-like disease.

Authors:  K B PETERSEN; P VON MAGNUS
Journal:  Dan Med Bull       Date:  1958-05

3.  Attenuated measles vaccine in children with acute leukemia.

Authors:  A MITUS; A HOLLOWAY; A E EVANS; J F ENDERS
Journal:  Am J Dis Child       Date:  1962-03

4.  Isolation and characterization of further defective clones of a temperature sensitive mutant (ts-1) of respiratory syncytial virus.

Authors:  L S Richardson; T J Schnitzer; R B Belshe; E Camargo; D A Prevar; R M Chanock
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  A comparison of the polypeptides of four measles virus strains.

Authors:  W E Mountcastle; P W Choppin
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

6.  Cells infected with a cell-associated subacute sclerosing panencephalitis virus do not express M protein.

Authors:  C E Machamer; E C Hayes; H J Zweerink
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

7.  The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses.

Authors:  W W Hall; R A Lamb; P W Choppin
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

Review 8.  Immunization against mumps.

Authors:  F Deinhardt; G J Shramek
Journal:  Prog Med Virol       Date:  1969

9.  Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults.

Authors:  P F Wright; J v Mills; R M Chanock
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

10.  Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Authors:  C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.